Medtronic’s VenaSeal Spectrum postmarket clinical trial program is highlighting the need for further patient-centric ...
IGSRT is endorsed as a first-line treatment for select NMSC cases, offering safety and efficacy with real-time imaging benefits. The therapy provides favorable cosmetic outcomes, especially in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback